Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HS-130 |
Trade Name | |
Synonyms | HS130|HS 130 |
Drug Descriptions |
HS-130 is a cancer vaccine, expressing a fusion of the OX40 ligand (TNFSF4) to an immunoglobulin, to activate an anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C165639 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HS-110 + HS-130 | HS-110 HS-130 | 0 | 1 |
HS-130 | HS-130 | 0 | 0 |